Yisheng Biopharma Funding: $170M Raised, Series B (2021)
Yisheng Biopharma is based in Beijing, China. It has raised $170M in total funding. Latest round: Series B.
Yisheng Biopharma funding overview
Yisheng Biopharma is based in Beijing, China. Yisheng Biopharma has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2021. The round record for Yisheng Biopharma runs through 2021; nothing later has been disclosed. Investors on record include Eight Roads, Oceanpine Capital, OrbiMed Advisors, F-Prime, 3W Partners, Hillhouse Capital. 6 distinct backers are named across the disclosed rounds.
Yisheng Biopharma has raised $170M in total disclosed funding across the rounds on record.
Who has invested in Yisheng Biopharma?
Eight Roads, Oceanpine Capital, OrbiMed Advisors, F-Prime, 3W Partners, Hillhouse Capital are named among the investors backing Yisheng Biopharma.
What was the latest Yisheng Biopharma funding round?
The most recent disclosed round is a Series B, announced in March 2021.
Where is Yisheng Biopharma based?
Yisheng Biopharma is based in Beijing, China.
When did Yisheng Biopharma last raise?
The last disclosed Yisheng Biopharma round closed in March 2021 at Series B.
Totals shown for Yisheng Biopharma aggregate every disclosed round on file. To see how that compares, browse the companies in Beijing and the investors behind them below.
